Morphic Therapeutic

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Immunic Therapeutics

The company develops oral therapies for chronic inflammatory and autoimmune diseases for patients with neurological and gastrointestinal conditions.

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

Ensho Therapeutics

This biopharmaceutical company develops oral small molecule therapies to treat patients suffering from inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Matchpoint Therapeutics

This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.